RATIONAL PHARMACOTHERAPY BASED ON PHARMACOECONOMIC DATA AUDIT: PRINCIPLES AND APPLICATION IN BULGARIA

RATIONAL PHARMACOTHERAPY BASED ON PHARMACOECONOMIC DATA AUDIT: PRINCIPLES AND APPLICATION IN BULGARIA

Show other versions (1)

The theoretical foundations of the application of pharmacoeconomic evaluations of pharmacotherapies in order to improve their economic efficiency and support the process of taking decisions on their payment from public funds are examined. An algorithm is presented for the pharmacoeconomic audit, whi...

Full description

Bibliographic Details
Main Author:	T. Vekov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	pharmacoeconomic audit economically rational pharmacotherapies reimbursement рositive list of medicines
Online Access:	https://www.rpcardio.online/jour/article/view/184

Similar Items

RATIONAL PHARMACOTHERAPY BASED ON PHARMACOECONOMIC DATA AUDIT: PRINCIPLES AND APPLICATION IN BULGARIA
by: T. Vekov
Published: (2015-09-01)

Editorial: Challenges of Pharmacoeconomics in Global Health Arena
by: Mihajlo Jakovljevic, et al.
Published: (2018-12-01)

Editorial: Challenges of pharmacoeconomics in global health arena—Contemporary momentum in the early 2020s
by: Mihajlo Jakovljevic, et al.
Published: (2023-04-01)

Systematic review of pharmacoeconomic models for schizophrenia
by: Junwen Zhou, et al.
Published: (2018-01-01)

RATIONAL PHARMACOTHERAPY IN TAKOTSUBO CARDIOMYOPATHY
by: S. Marchev, et al.
Published: (2015-12-01)

Pharmacoeconomics as an instrument of clinical pharmacology for optimization of pharmacotherapy
by: Reshetko O.V., et al.
Published: (2015-09-01)

Pharmacoeconomic aspects of pharmaceutical ethics
by: Huk Karina Ruslanivna, et al.
Published: (2022-01-01)

Pharmacoeconomic studies in Nepal: The need of the hour
by: Mahip eAcharya
Published: (2014-12-01)

Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia
by: V. G. Deriushkin, et al.
Published: (2021-02-01)

Pharmacoeconomics as an instrument of clinical pharmacology for optimization of pharmacotherapy (review)
by: O. V. Reshet'ko, et al.
Published: (2018-02-01)

Pharmacoeconomic research of pharmacotherapy schemes of community-acquired pneumonia with the inclusion of antiviral drugs
by: S. O. Soloviov, et al.
Published: (2020-03-01)

An Audit of Rational Use of Antibiotics in a Tertiary Hospital
by: Tanzima Begum, et al.
Published: (2014-07-01)

Pharmacoeconomic analysis of various adjunctive pharmacotherapy strategies for back pain using comparative method
by: P. A. Balunov
Published: (2018-04-01)

Cost-effectiveness thresholds or decision-making threshold: a novel perspective
by: Lihua Sun, et al.
Published: (2023-10-01)

Pharmacoeconomics of Bronchial Asthma
by: Ivanova Zlatina I., et al.
Published: (2019-06-01)

Pharmacoeconomic analysis in various nosologies
by: A. A. Svistunov, et al.
Published: (2022-12-01)

Drug Audit of Intravenous Anaesthetic Agents in Tertiary Care Hospital
by: Sonali Ramakant More, et al.
Published: (2015-11-01)

PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review
by: T. S. Romanenko, et al.
Published: (2015-09-01)

Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children
by: E. Petro, et al.
Published: (2024-12-01)

Implementation of Country-Wide Pharmacoeconomic Principles in Cancer Care in Developing Countries: Expert-Based Recommendations
by: Abdul Rahman Jazieh, et al.
Published: (2019-10-01)

Analysis of effectiveness criteria in pharmacoeconomic studies of antimicrobial agents proposed for inclusion in the Russian essential drug list in the 2014 -2016
by: Gomon Yu.M., et al.
Published: (2017-08-01)

Pharmacoeconomic effectiveness of phytotherapy in complex treatment of pyelonephritis
by: V. V. Ivanov, et al.
Published: (2015-04-01)

Development conceptual of pharmacoeconomic model of technology for early diagnosis and pharmacotherapy of pulmonary arterial hypertension
by: I. S. Datsenko
Published: (2022-12-01)

Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia
by: N. A. Avxentyev, et al.
Published: (2018-08-01)

Synthesis, modulation of electromagnetic properties of FeCo/PPy nanocomposites
by: YAN Zhi-ran, et al.
Published: (2019-03-01)

Current Situation and Prospect of Pharmacoeconomic Evaluation of Hemophilia in China
by: LI Shunping, et al.
Published: (2022-10-01)

ECONOMIC RATIONALITY OF AGRICULTURAL ENTREPRENEURS IN BULGARIA
by: T. Taneva, et al.
Published: (2019-10-01)

Method of quality improvement and economic efficiency of pharmacotherapy for community-acquired pneumonia and its utility in Ukraine health-care facilities
by: A.B. Zimenkovsky
Published: (2020-09-01)

THE FEATURES OF METHODOLOGY FOR PHARMACOECONOMICS ANALYSIS OF VACCINATION
by: A. Yu. Kulikov, et al.
Published: (2015-03-01)

Scientific substantiation of the concept of pharmacoeconomic analysis of technologies for early diagnosis and pharmacotherapy of pulmonary arterial hypertension
by: I. S. Datsenko, et al.
Published: (2022-10-01)

Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results
by: Junwen Zhou, et al.
Published: (2019-01-01)

Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review
by: Mori Amani, et al.
Published: (2012-09-01)

Evidence of Chinese Herbal Medicine Use From an Economic Perspective: A Systematic Review of Pharmacoeconomics Studies Over Two Decades
by: Xiaomo Xiong, et al.
Published: (2022-05-01)

Pharmacoeconomics in Africa: needs, prospect and challenges
by: Temitope Ben-Ajepe, et al.
Published: (2021-12-01)

Outlook of Pharmacoeconomics and its status in Nepal
by: Sabita Paudel
Published: (2018-03-01)

Pharmacoeconomic particulars of ovaries cancer’s treatment
by: V N Zhurman, et al.
Published: (2015-06-01)

Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment
by: Milewska S, et al.
Published: (2021-09-01)

Development of a pharmacoeconomic registry: an example using hormonal contraceptives
by: Annesha White, et al.
Published: (2021-03-01)

Rational treatment of patients with functional dyspepsia
by: Alexander S. Kazakov, et al.
Published: (2021-08-01)

Pharmacoeconomic aspects of COVID-19 treatment
by: I. V. Rogova, et al.
Published: (2021-10-01)